체외 단백질 발현 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

In Vitro Protein Expression Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 2024년 체외 단백질 발현 시장 규모(2024년) : 2억 3,950만 달러
• 시장 규모 예측(2031년) : 3억 8,590만 달러
• 세계 시장 성장률(2024-2031년) : CAGR 7.1%

시장 성장 촉진요인:

세계 체외 단백질 발현 시장의 성장을 이끄는 요인으로는 단백질 기반 치료제에 대한 수요 증가, 신약 개발 과정에서 신속한 단백질 합성의 필요성, 맞춤형 의료에 대한 관심 증가 등이 있습니다. 분자생물학적 기술의 발전과 강력한 발현 시스템의 가용성이 이러한 성장을 촉진하고 있습니다. 또한, 정부의 생명공학 연구에 대한 재정적 지원과 학술 기관과 바이오 제약 기업 간의 파트너십도 시장 확대에 기여하고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고, 체외 단백질 발현 시장은 특정 과제에 직면해 있습니다. 단백질 발현 시스템 및 시약과 관련된 높은 비용은 특히 중소기업에 큰 장벽이 되고 있습니다. 또한, 기술적 복잡성과 숙련된 인력의 필요성이 시장 보급을 더욱 억제하고 있습니다. 또한, 재조합 단백질의 치료제 사용에 대한 규제 문제도 시장 성장을 제한할 수 있습니다.

시장 기회:

인비트로 단백질 발현 시장은 고처리량 스크리닝 애플리케이션에서 무세포 단백질 합성의 채택이 증가함에 따라 큰 성장 기회를 맞이하고 있습니다. 비용 효율적이고 효율적인 발현 시스템의 개발로 인해 시장의 매력은 더욱 커질 것으로 예상됩니다. 또한, 합성생물학의 중요성이 부각되고 CRISPR-Cas9와 같은 유전자 편집 기술의 발전은 기술 혁신의 새로운 길을 열어줄 것입니다. 항체 개발, 백신 생산, 바이오센서 설계 등의 분야에서 단백질 발현 시장의 발전은 시장 기회를 더욱 확대시키고 있습니다.

세계의 체외 단백질 발현 시장을 조사했으며, 시장의 정의와 개요, 시장 촉진·억제요인, 각종 동향, 시장 기회와 과제, 시장 규모(금액, 일부 수량) 추이와 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 분류
• 시장 정의
• 제품 비교

제3장 시장 관점

• 거시경제 요인
• 성장 촉진요인
  • 공급측 요인
  • 수요측 요인
• 성장 억제요인
• 기회 분석
• 동향
• 지역별 가격 분석
• 주요 인사이트

제4장 북미의 체외 단백질 발현 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 미국
  • 캐나다
• 시장 규모 추정과 예측 : 제품 유형별
  • 대장균
  • 토끼 망상 적혈구
  • 밀배아
  • 곤충 세포
  • 포유류
• 시장 규모 추정과 예측 : 용도별
  • 효소 공학
  • 단백질 표지
  • 단백질간 상호작용
  • 단백질 정제
• 시장 규모 추정과 예측 : 발현 시스템별
  • 연속 플로우 발현 시스템
  • 배치 발현 시스템
• 시장 규모 추정과 예측 : 최종사용자별
  • 바이오테크놀러지 기업
  • 제약회사
  • CRO
  • 학술연구기관
• 시장 매력 분석
• 성장 촉진요인과 억제요인 : 영향 분석
• 주요 참여자 시장 입지(강도 맵)

제5장 라틴아메리카의 체외 단백질 발현 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 발현 시스템별
• 시장 규모 추정과 예측 : 최종사용자별
• 시장 매력 분석
• 성장 촉진요인과 억제요인 : 영향 분석
• 주요 참여자 시장 입지(강도 맵)

제6장 유럽의 체외 단백질 발현 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 영국
  • 독일
  • 프랑스
  • 스페인
  • 이탈리아
  • 폴란드
  • 러시아
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 발현 시스템별
• 시장 규모 추정과 예측 : 최종사용자별
• 시장 매력 분석
• 성장 촉진요인과 억제요인 : 영향 분석
• 주요 참여자 시장 입지(강도 맵)

제7장 아시아태평양의 체외 단백질 발현 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 중국
  • 일본
  • 호주
  • 인도
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 발현 시스템별
• 시장 규모 추정과 예측 : 최종사용자별
• 시장 매력 분석
• 성장 촉진요인과 억제요인 : 영향 분석
• 주요 참여자 시장 입지(강도 맵)

제8장 중동 및 아프리카의 체외 단백질 발현 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • GCC 국가
  • 남아프리카공화국
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 발현 시스템별
• 시장 규모 추정과 예측 : 최종사용자별
• 시장 매력 분석
• 성장 촉진요인과 억제요인 : 영향 분석
• 주요 참여자 시장 입지(강도 맵)

제9장 예측요인 : 관련성과 영향

제10장 경쟁 구도

• 시장 구조
• 기업 점유율 분석
• 경쟁 대시보드
• 기업 개요(상세 : 개요, 재무, 전략, 최근 동향, SWOT 분석)
  • Thermo Fisher Scientific, Inc.
  • Takara Bio Company
  • New England Biolabs
  • Promega Corporation
  • Jena Bioscience GmbH
  • GeneCopoeia, Inc.
  • Biotechrabbit GmbH
  • Cube Biotech GmbH
  • CellFree Sciences Co., Ltd.
  • Bioneer Corporation

제11장 세계의 체외 단백질 발현 시장 분석과 예측 : 지역별

제12장 세계의 체외 단백질 발현 시장 분석과 예측 : 제품 유형별

제13장 세계의 체외 단백질 발현 시장 분석과 예측 : 용도별

제14장 세계의 체외 단백질 발현 시장 분석과 예측 : 발현 시스템별

제15장 세계의 체외 단백질 발현 시장 분석과 예측 : 최종사용자별

제16장 세계 시장 분석과 예측

• 수익 기회
• 시장 규모·전년비 성장률
• 밸류체인

제17장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global In Vitro Protein Expression Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• In Vitro Protein Expression Market Size (2024E): US$239.5 Mn
• Projected Market Value (2031F): US$385.9 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 7.1%

In Vitro Protein Expression Market - Report Scope:

The global in vitro protein expression market encompasses a wide range of expression systems, including cell-free protein expression, prokaryotic expression systems, and eukaryotic expression systems. Market growth is primarily fueled by the increasing demand for recombinant protein production, advancements in synthetic biology, and the rising adoption of cell-free protein synthesis technologies. The market's expansion is further supported by growing research activities in proteomics and the pharmaceutical sector.

Market Growth Drivers:

Several factors are driving the growth of the global in vitro protein expression market. These include the escalating demand for protein-based therapeutics, the need for rapid protein synthesis in drug discovery processes, and the increasing focus on personalized medicine. Advancements in molecular biology techniques and the availability of robust expression systems are facilitating this growth. Additionally, government funding for biotechnological research and partnerships between academic institutions and biopharma companies contribute to market expansion.

Market Restraints:

Despite the promising growth prospects, the in vitro protein expression market faces certain challenges. High costs associated with protein expression systems and reagents act as significant barriers, particularly for small and medium-sized enterprises. Technical complexities and the need for skilled personnel further restrict market penetration. Moreover, the regulatory challenges related to the use of recombinant proteins in therapeutics may limit the market's growth potential.

Market Opportunities:

The in vitro protein expression market presents significant growth opportunities driven by the rising adoption of cell-free protein synthesis for high-throughput screening applications. The development of cost-effective and efficient expression systems is expected to attract more players to the market. Additionally, the growing emphasis on synthetic biology and advancements in gene-editing technologies like CRISPR-Cas9 open new avenues for innovation. Expanding applications of protein expression in areas such as antibody development, vaccine production, and biosensor design further enhance market opportunities.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the in vitro protein expression market?
• Which expression systems are gaining the highest adoption across different regions?
• How are technological innovations influencing the competitive landscape of the in vitro protein expression market?
• Who are the key players in the in vitro protein expression market, and what strategies are they employing to maintain their market positions?
• What are the emerging trends and future outlooks for the global in vitro protein expression market?

Competitive Intelligence and Business Strategy:

Leading companies in the global in vitro protein expression market, such as Thermo Fisher Scientific Inc., Merck KGaA, and Promega Corporation, are focusing on product innovation and expanding their portfolios of expression systems. These companies are heavily investing in the development of advanced technologies for protein synthesis and establishing strategic partnerships with research institutes. Emphasis on sustainability and the introduction of eco-friendly reagents are emerging trends in the competitive landscape.

Key Companies Profiled:

• Thermo Fisher Scientific, Inc.
• Takara Bio Company
• New England Biolabs
• Promega Corporation
• Jena Bioscience GmbH
• GeneCopoeia, Inc.
• Biotechrabbit GmbH
• Cube Biotech GmbH
• CellFree Sciences Co., Ltd.
• Bioneer Corporation
• Others.

In Vitro Protein Expression Industry Research by Category:

By Product Type

• coli System
• Rabbit Reticulocytes System
• Wheat Germ System
• Insect Cells System
• Mammalian System

By Expression Mode

• Continuous Flow Expression
• Batch Expression

By End User

• Biotechnological Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Academic and Research Institutes

By Application

• Enzyme Engineering
• Protein Labeling
• Protein-Protein Interaction
• Protein Purification

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• MEA

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Taxonomy
• 2.2. Market Definition
• 2.3. Product Comparison

3. Market View Point

• 3.1. Macro-Economic Factors
• 3.2. Drivers
  • 3.2.1. Supply Side Drivers
  • 3.2.2. Demand Side Drivers
• 3.3. Restraints
• 3.4. Opportunity Analysis
• 3.5. Trends
• 3.6. Pricing Analysis by Region
• 3.7. Primary Insights and Verbatim

4. North America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 4.1. Introduction
• 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 4.2.1. U.S.
  • 4.2.2. Canada
• 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 4.3.1. U.S.
  • 4.3.2. Canada
• 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 4.4.1. E-coli In-Vitro Protein Expression System
  • 4.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 4.4.3. Wheat Germ In-Vitro Protein Expression System
  • 4.4.4. Insect Cells In-Vitro Protein Expression System
  • 4.4.5. Mammalian In-Vitro Protein Expression System
• 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 4.5.1. E-coli In-Vitro Protein Expression System
  • 4.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 4.5.3. Wheat Germ In-Vitro Protein Expression System
  • 4.5.4. Insect Cells In-Vitro Protein Expression System
  • 4.5.5. Mammalian In-Vitro Protein Expression System
• 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 4.6.1. Enzyme Engineering
  • 4.6.2. Protein Labeling
  • 4.6.3. Protein-Protein interaction
  • 4.6.4. Protein Purification
• 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 4.7.1. Enzyme Engineering
  • 4.7.2. Protein Labeling
  • 4.7.3. Protein-Protein interaction
  • 4.7.4. Protein Purification
• 4.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 4.8.1. Continuous Flow Expression System
  • 4.8.2. Batch Expression System
• 4.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 4.9.1. Continuous Flow Expression System
  • 4.9.2. Batch Expression System
• 4.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 4.10.1. Biotechnological Companies
  • 4.10.2. Pharmaceutical Companies
  • 4.10.3. Contract Research Organizations
  • 4.10.4. Academic and Research Institutes
• 4.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 4.11.1. Biotechnological Companies
  • 4.11.2. Pharmaceutical Companies
  • 4.11.3. Contract Research Organizations
  • 4.11.4. Academic and Research Institutes
• 4.12. Market Attractiveness Analysis
  • 4.12.1. By Country
  • 4.12.2. By Product Type
  • 4.12.3. By Application
  • 4.12.4. By Expression System
  • 4.12.5. By End User
• 4.13. Drivers and Restraints: Impact Analysis
• 4.14. Key Participants Market Presence (Intensity Map)

5. Latin America In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 5.1. Introduction
• 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 5.2.1. Brazil
  • 5.2.2. Mexico
  • 5.2.3. Argentina
  • 5.2.4. Rest of Latin America
• 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 5.3.1. Brazil
  • 5.3.2. Mexico
  • 5.3.3. Argentina
  • 5.3.4. Rest of Latin America
• 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 5.4.1. E-coli In-Vitro Protein Expression System
  • 5.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 5.4.3. Wheat Germ In-Vitro Protein Expression System
  • 5.4.4. Insect Cells In-Vitro Protein Expression System
  • 5.4.5. Mammalian In-Vitro Protein Expression System
• 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 5.5.1. E-coli In-Vitro Protein Expression System
  • 5.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 5.5.3. Wheat Germ In-Vitro Protein Expression System
  • 5.5.4. Insect Cells In-Vitro Protein Expression System
  • 5.5.5. Mammalian In-Vitro Protein Expression System
• 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 5.6.1. Enzyme Engineering
  • 5.6.2. Protein Labeling
  • 5.6.3. Protein-Protein interaction
  • 5.6.4. Protein Purification
• 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 5.7.1. Enzyme Engineering
  • 5.7.2. Protein Labeling
  • 5.7.3. Protein-Protein interaction
  • 5.7.4. Protein Purification
• 5.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 5.8.1. Continuous Flow Expression System
  • 5.8.2. Batch Expression System
• 5.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 5.9.1. Continuous Flow Expression System
  • 5.9.2. Batch Expression System
• 5.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 5.10.1. Biotechnological Companies
  • 5.10.2. Pharmaceutical Companies
  • 5.10.3. Contract Research Organizations
  • 5.10.4. Academic and Research Institutes
• 5.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 5.11.1. Biotechnological Companies
  • 5.11.2. Pharmaceutical Companies
  • 5.11.3. Contract Research Organizations
  • 5.11.4. Academic and Research Institutes
• 5.12. Market Attractiveness Analysis
  • 5.12.1. By Country
  • 5.12.2. By Product Type
  • 5.12.3. By Application
  • 5.12.4. By Expression System
  • 5.12.5. By End User
• 5.13. Drivers and Restraints: Impact Analysis
• 5.14. Key Participants Market Presence (Intensity Map)

6. Europe In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 6.1. Introduction
• 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 6.2.1. U.K
  • 6.2.2. Germany
  • 6.2.3. France
  • 6.2.4. Spain
  • 6.2.5. Italy
  • 6.2.6. Poland
  • 6.2.7. Russia
  • 6.2.8. Rest of Europe
• 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 6.3.1. U.K
  • 6.3.2. Germany
  • 6.3.3. France
  • 6.3.4. Spain
  • 6.3.5. Italy
  • 6.3.6. Poland
  • 6.3.7. Russia
  • 6.3.8. Rest of Europe
• 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 6.4.1. E-coli In-Vitro Protein Expression System
  • 6.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 6.4.3. Wheat Germ In-Vitro Protein Expression System
  • 6.4.4. Insect Cells In-Vitro Protein Expression System
  • 6.4.5. Mammalian In-Vitro Protein Expression System
• 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 6.5.1. E-coli In-Vitro Protein Expression System
  • 6.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 6.5.3. Wheat Germ In-Vitro Protein Expression System
  • 6.5.4. Insect Cells In-Vitro Protein Expression System
  • 6.5.5. Mammalian In-Vitro Protein Expression System
• 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 6.6.1. Enzyme Engineering
  • 6.6.2. Protein Labeling
  • 6.6.3. Protein-Protein interaction
  • 6.6.4. Protein Purification
• 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 6.7.1. Enzyme Engineering
  • 6.7.2. Protein Labeling
  • 6.7.3. Protein-Protein interaction
  • 6.7.4. Protein Purification
• 6.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 6.8.1. Continuous Flow Expression System
  • 6.8.2. Batch Expression System
• 6.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 6.9.1. Continuous Flow Expression System
  • 6.9.2. Batch Expression System
• 6.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 6.10.1. Biotechnological Companies
  • 6.10.2. Pharmaceutical Companies
  • 6.10.3. Contract Research Organizations
  • 6.10.4. Academic and Research Institutes
• 6.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 6.11.1. Biotechnological Companies
  • 6.11.2. Pharmaceutical Companies
  • 6.11.3. Contract Research Organizations
  • 6.11.4. Academic and Research Institutes
• 6.12. Market Attractiveness Analysis
  • 6.12.1. By Country
  • 6.12.2. By Product Type
  • 6.12.3. By Application
  • 6.12.4. By Expression System
  • 6.12.5. By End User
• 6.13. Drivers and Restraints: Impact Analysis
• 6.14. Key Participants Market Presence (Intensity Map)

7. Asia Pacific In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 7.1. Introduction
• 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 7.2.1. China
  • 7.2.2. Japan
  • 7.2.3. Australia
  • 7.2.4. India
  • 7.2.5. Rest of Asia-Pacific
• 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
  • 7.3.1. China
  • 7.3.2. Japan
  • 7.3.3. Australia
  • 7.3.4. India
  • 7.3.5. Rest of Asia Pacific
• 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 7.4.1. E-coli In-Vitro Protein Expression System
  • 7.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 7.4.3. Wheat Germ In-Vitro Protein Expression System
  • 7.4.4. Insect Cells In-Vitro Protein Expression System
  • 7.4.5. Mammalian In-Vitro Protein Expression System
• 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 7.5.1. E-coli In-Vitro Protein Expression System
  • 7.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 7.5.3. Wheat Germ In-Vitro Protein Expression System
  • 7.5.4. Insect Cells In-Vitro Protein Expression System
  • 7.5.5. Mammalian In-Vitro Protein Expression System
• 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 7.6.1. Enzyme Engineering
  • 7.6.2. Protein Labeling
  • 7.6.3. Protein-Protein interaction
  • 7.6.4. Protein Purification
• 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 7.7.1. Enzyme Engineering
  • 7.7.2. Protein Labeling
  • 7.7.3. Protein-Protein interaction
  • 7.7.4. Protein Purification
• 7.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 7.8.1. Continuous Flow Expression System
  • 7.8.2. Batch Expression System
• 7.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 7.9.1. Continuous Flow Expression System
  • 7.9.2. Batch Expression System
• 7.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 7.10.1. Biotechnological Companies
  • 7.10.2. Pharmaceutical Companies
  • 7.10.3. Contract Research Organizations
  • 7.10.4. Academic and Research Institutes
• 7.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 7.11.1. Biotechnological Companies
  • 7.11.2. Pharmaceutical Companies
  • 7.11.3. Contract Research Organizations
  • 7.11.4. Academic and Research Institutes
• 7.12. Market Attractiveness Analysis
  • 7.12.1. By Country
  • 7.12.2. By Product Type
  • 7.12.3. By Application
  • 7.12.4. By Expression System
  • 7.12.5. By End User
• 7.13. Drivers and Restraints: Impact Analysis
• 7.14. Key Participants Market Presence (Intensity Map)

8. MEA In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
  • 8.2.1. GCC Countries
  • 8.2.2. South Africa
  • 8.2.3. Rest of MEA
• 8.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
  • 8.3.1. GCC Countries
  • 8.3.2. South Africa
  • 8.3.3. Rest of MEA
• 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 8.4.1. E-coli In-Vitro Protein Expression System
  • 8.4.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 8.4.3. Wheat Germ In-Vitro Protein Expression System
  • 8.4.4. Insect Cells In-Vitro Protein Expression System
  • 8.4.5. Mammalian In-Vitro Protein Expression System
• 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 8.5.1. E-coli In-Vitro Protein Expression System
  • 8.5.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 8.5.3. Wheat Germ In-Vitro Protein Expression System
  • 8.5.4. Insect Cells In-Vitro Protein Expression System
  • 8.5.5. Mammalian In-Vitro Protein Expression System
• 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 8.6.1. Enzyme Engineering
  • 8.6.2. Protein Labeling
  • 8.6.3. Protein-Protein interaction
  • 8.6.4. Protein Purification
  • 8.6.5. Targeted Sequencing
• 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 8.7.1. Enzyme Engineering
  • 8.7.2. Protein Labeling
  • 8.7.3. Protein-Protein interaction
  • 8.7.4. Protein Purification
• 8.8. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 8.8.1. Continuous Flow Expression System
  • 8.8.2. Batch Expression System
• 8.9. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 8.9.1. Continuous Flow Expression System
  • 8.9.2. Batch Expression System
• 8.10. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 8.10.1. Biotechnological Companies
  • 8.10.2. Pharmaceutical Companies
  • 8.10.3. Contract Research Organizations
  • 8.10.4. Academic and Research Institutes
• 8.11. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 8.11.1. Biotechnological Companies
  • 8.11.2. Pharmaceutical Companies
  • 8.11.3. Contract Research Organizations
  • 8.11.4. Academic and Research Institutes
• 8.12. Market Attractiveness Analysis
  • 8.12.1. By Country
  • 8.12.2. By Product Type
  • 8.12.3. By Application
  • 8.12.4. By Expression System
  • 8.12.5. By End User
• 8.13. Drivers and Restraints: Impact Analysis
• 8.14. Key Participants Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Competition Landscape

• 10.1. Market Structure
• 10.2. Company Share Analysis (2024)
• 10.3. Competition Dashboard
• 10.4. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments and SWOT Analysis)
  • 10.4.1. Thermo Fisher Scientific, Inc.
  • 10.4.2. Takara Bio Company
  • 10.4.3. New England Biolabs
  • 10.4.4. Promega Corporation
  • 10.4.5. Jena Bioscience GmbH
  • 10.4.6. GeneCopoeia, Inc.
  • 10.4.7. Biotechrabbit GmbH
  • 10.4.8. Cube Biotech GmbH
  • 10.4.9. CellFree Sciences Co., Ltd.
  • 10.4.10. Bioneer Corporation

11. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

• 11.1. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
  • 11.1.1. North America
  • 11.1.2. Latin America
  • 11.1.3. Europe
  • 11.1.4. Asia Pacific
  • 11.1.5. Middle East and Africa
• 11.2. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
  • 11.2.1. North America
  • 11.2.2. Latin America
  • 11.2.3. Europe
  • 11.2.4. Asia Pacific
  • 11.2.5. Middle East and Africa
• 11.3. Market Attractiveness Analysis By Region

12. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
  • 12.2.1. E-coli In-Vitro Protein Expression System
  • 12.2.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 12.2.3. Wheat Germ In-Vitro Protein Expression System
  • 12.2.4. Insect Cells In-Vitro Protein Expression System
  • 12.2.5. Mammalian In-Vitro Protein Expression System
• 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
  • 12.3.1. E-coli In-Vitro Protein Expression System
  • 12.3.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  • 12.3.3. Wheat Germ In-Vitro Protein Expression System
  • 12.3.4. Insect Cells In-Vitro Protein Expression System
  • 12.3.5. Mammalian In-Vitro Protein Expression System
• 12.4. Market Attractiveness Analysis By Product Type

13. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
  • 13.2.1. Enzyme Engineering
  • 13.2.2. Protein Labeling
  • 13.2.3. Protein-Protein interaction
  • 13.2.4. Protein Purification
• 13.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
  • 13.3.1. Enzyme Engineering
  • 13.3.2. Protein Labeling
  • 13.3.3. Protein-Protein interaction
  • 13.3.4. Protein Purification
• 13.4. Market Attractiveness Analysis By Application

14. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Expression System

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Expression System, 2019 - 2023
  • 14.2.1. Continuous Flow Expression System
  • 14.2.2. Batch Expression System
• 14.3. Market Size (US$ Mn) Forecast By Expression System, 2024 - 2031
  • 14.3.1. Continuous Flow Expression System
  • 14.3.2. Batch Expression System
• 14.4. Market Attractiveness Analysis By Expression System

15. Global In-Vitro Protein Expression Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
  • 15.2.1. Biotechnological Companies
  • 15.2.2. Pharmaceutical Companies
  • 15.2.3. Contract Research Organizations
  • 15.2.4. Academic and Research Institutes
• 15.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
  • 15.3.1. Biotechnological Companies
  • 15.3.2. Pharmaceutical Companies
  • 15.3.3. Contract Research Organizations
  • 15.3.4. Academic and Research Institutes
• 15.4. Market Attractiveness Analysis By End User

16. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 16.1. Market Size Analysis and Y-o-Y Growth
• 16.2. Absolute $ Opportunity
• 16.3. Market Volume and Y-o-Y Growth
• 16.4. Value Chain

17. Research Methodology

관련자료